Advanced Urology Associates

News and Announcements

Urologist Treating Patients with UroLift System

Becomes 1st Midwest physician to reach 200

“The UroLift System is a breakthrough treatment that typically takes less than an hour and can offer multiple benefits for men with enlarged prostate – an alternative to invasive surgery without cutting, heating or removing tissue.”
Gregory Andros,
Joliet Urologist

Joliet urologist Gregory Andros, M.D., announced that his 200th patient has been treated with the UroLift System, a proven, minimally invasive technology to treat men suffering from symptoms associated with benign prostatic hyperplasia.

Andros is the first physician in the Midwest to reach this milestone, performing more UroLift System procedures than any other doctor in the area and in the top 25 of all physicians in the country.

“The UroLift System is a breakthrough treatment that typically takes less than an hour and can offer multiple benefits for men with enlarged prostate – an alternative to invasive surgery without cutting, heating or removing tissue,” Andros said. “In addition, the procedure involves minimal downtime, preservation of sexual function, and does not require ongoing continued medications.

“Hearing firsthand the experiences of more than 200 patients reaffirms that we are providing the best care possible for our patients and that this procedure is changing lives.”

Nearly 40 million men in the U.S. are affected by BPH. Not to be confused with prostate cancer, BPH occurs when the prostate gland that surrounds the male urethra becomes enlarged with advancing age and begins to obstruct the urinary system.

Symptoms of BPH often include interrupted sleep and urinary problems, and can cause loss of productivity, depression and decreased quality of life.

Five-year data from a randomized study show that the UroLift System offers not only rapid improvement, but also durable relief for patients with BPH.

After five years, patients treated with the UroLift System continue to experience symptom relief with minimal side effects, with few patients requiring an additional procedure for relief.

A second, randomized clinical trial called BPH6 demonstrated that the minimally invasive UroLift System compares with the reference standard surgery, transurethral resection of the prostate, with regard to efficacy, and is superior to TURP at preserving sexual function and offering a more rapid recovery.

Medication often is the first line of therapy for enlarged prostate, but relief can be inadequate and temporary.

Side effects of medication treatment can include sexual dysfunction, dizziness and headaches, prompting many patients to quit using the drugs.

For these patients, the classic alternative is surgery that cuts, heats or removes prostate tissue to open the blocked urethra.

Although current surgical options can be very effective in relieving symptoms, they also can leave patients with permanent side effects, such as urinary incontinence, erectile dysfunction and retrograde ejaculation.